A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
J Hugosson, MJ Roobol, M Månsson, TLJ Tammela… - European urology, 2019 - Elsevier
Abstract Background The European Randomized study of Screening for Prostate Cancer
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …
Prostate cancer mortality in the Finnish randomized screening trial
TP Kilpeläinen, TL Tammela, N Malila… - Journal of the …, 2013 - academic.oup.com
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …
shown to decrease PC mortality by the European Randomized Study of Screening for …
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
MJ Roobol, R Kranse, CH Bangma, AG van Leenders… - European urology, 2013 - Elsevier
Background Evidence from randomized trials on the effects of screening for prostate cancer
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
Prostate-cancer mortality at 11 years of follow-up
FH Schröder, J Hugosson, MJ Roobol… - … England Journal of …, 2012 - Mass Medical Soc
Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …
Screening and prostate-cancer mortality in a randomized European study
FH Schröder, J Hugosson, MJ Roobol… - New England journal …, 2009 - Mass Medical Soc
Background The European Randomized Study of Screening for Prostate Cancer was
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …
Prostate cancer mortality reduction by prostate-specific antigen–based screening adjusted for nonattendance and contamination in the European Randomised Study …
BACKGROUND: Prostate-specific antigen (PSA) based screening for prostate cancer (PCa)
has been shown to reduce prostate specific mortality by 20% in an intention to screen (ITS) …
has been shown to reduce prostate specific mortality by 20% in an intention to screen (ITS) …
[HTML][HTML] Relationship between baseline prostate-specific antigen on cancer detection and prostate cancer death: long-term follow-up from the European randomized …
S Remmers, CH Bangma, RA Godtman, SV Carlsson… - European urology, 2023 - Elsevier
Abstract Background The European Association of Urology guidelines recommend a risk-
based strategy for prostate cancer screening based on the first prostate-specific antigen …
based strategy for prostate cancer screening based on the first prostate-specific antigen …
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela… - The Lancet, 2014 - thelancet.com
Summary Background The European Randomised study of Screening for Prostate Cancer
(ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 …
(ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 …
Prostate-specific antigen screening and 15-year prostate cancer mortality: a secondary analysis of the CAP randomized clinical trial
Importance The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP)
reported no effect of prostate-specific antigen (PSA) screening on prostate cancer mortality …
reported no effect of prostate-specific antigen (PSA) screening on prostate cancer mortality …
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer—results from a prospective, population-based randomized …
G Aus, S Bergdahl, P Lodding, H Lilja, J Hugosson - European urology, 2007 - Elsevier
OBJECTIVES: Randomized controlled trials are currently conducted to assess whether the
mortality from prostate cancer is reduced by early detection with the use of prostate-specific …
mortality from prostate cancer is reduced by early detection with the use of prostate-specific …